Discontinuation rates due to adverse effects were also higher with retatrutide being 16-17% compared with 2% with dulaglutide and 0-4% with placebo
In the first few weeks of treatment, some individuals may experience mild gastrointestinal side effects such as nausea, bloating, or occasional diarrhea
Ahles S, Joris PJ, Plat J
J Diabetes Sci Technol 4:13221331 Gelling RW, Du XQ, Dichmann DS et al (2003) Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice
Tirzepatide is another useful drug for the treatment of obesity commercialised under the name Mounjaro which has later appeared to increase the arsenal of useful drugs for the treatment of obesity and marketed in Spain from 1 July 2024
As well as these broader systemic effects, it has also been suggested that DPP-4 may be able to modulate -cell function as part of a paracrine system involving GLP-1 produced locally within the pancreatic islets